TickerLeague

Market Cap for Insulet (PODD)

According to Insulet's latest reported financial statements, the company's latest reported market cap is $20.09B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$20.09B

YoY change

-43.7%

5Y CAGR

-8.8%

Peak year (2022)

$20.58B

Latest annual

$11.50B

Market Cap history chart for Insulet (PODD) from 2007 to 2026

Market Cap history table for Insulet (PODD) from 2007 to 2026

Fiscal yearPeriod endedReportedMarket CapYoY
2026$11.50B-43.7%
2025$20.43B+5.9%
2024$19.29B+20.7%
2023$15.98B-22.4%
2022$20.58B+12.8%
2021$18.25B+8.2%
2020$16.86B+58.0%
2019$10.67B+120.4%
2018$4.84B+20.9%
2017$4.00B+85.5%
2016$2.16B+0.5%
2015$2.15B-16.2%
2014$2.56B+27.9%
2013$2.00B+97.0%
2012$1.02B+15.7%
2011$879.17M+43.2%
2010$613.92M+44.6%
2009$424.50M+99.2%
2008$213.16M-45.6%
2007$391.84M

Market Cap values are taken from Insulet's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

The 2026 reading of Insulet (PODD) market cap is $11.50B – plunged 43.7% year-over-year.

Through 2021–2026 (5 years), Insulet market cap delivered a -8.8% annualised rate; with a net decline across the window.

Between 2022 and 2026, Insulet market cap plunged 44.1%, falling from $20.58B to $11.50B.

The dataset's maximum market cap sits at $20.58B (2022); the minimum reading of $213.16M dates to 2008.

Within Healthcare, Insulet (PODD) ranks 9th among 8 peers we track. The peer median for market cap is $311.16B.

Insulet Market Cap by Year

Insulet Market Cap 2026: $11.50B

Insulet market cap in 2026 was $11.50B, plunged 43.7% below 2025.

Insulet Market Cap 2025: $20.43B

Insulet market cap in 2025 was $20.43B, grew 5.9% from 2024.

Insulet Market Cap 2024: $19.29B

Insulet market cap in 2024 was $19.29B, grew 20.7% from 2023.

Insulet Market Cap 2023: $15.98B

Insulet market cap in 2023 was $15.98B, declined 22.4% below 2022.

Insulet Market Cap 2022: $20.58B

Insulet market cap in 2022 was $20.58B.

See more financial history for Insulet (PODD).

Sector peers — Market Cap

Companies in the same sector as Insulet, ranked by their latest market cap.

CompanyMarket CapSector
Eli Lilly and Company (LLY)$825.77BHealthcare
Johnson & Johnson (JNJ)$548.34BHealthcare
AbbVie Inc. (ABBV)$349.67BHealthcare
UnitedHealth Group Incorporated (UNH)$332.91BHealthcare
AstraZeneca PLC (AZN)$289.41BHealthcare
Merck & Co., Inc. (MRK)$272.11BHealthcare
Amgen Inc. (AMGN)$183.05BHealthcare
Novo Nordisk A/S (NVO)$182.96BHealthcare

Frequently asked questions

What is Insulet's market cap?

Latest reported market cap for Insulet (PODD) is $20.09B (period ending December 31, 2025).

How has Insulet market cap changed year-over-year?

Insulet (PODD) market cap changed -43.7% year-over-year on the latest annual filing.

What is the long-term growth rate of Insulet market cap?

Insulet (PODD) market cap compound annual growth rate is -8.8% over the most recent 5 years available.

When did Insulet market cap hit its highest annual value?

Insulet market cap reached its highest annual value of $20.58B in 2022.

What was Insulet market cap in 2025?

Insulet (PODD) market cap in 2025 was $20.43B.

What was Insulet market cap in 2026?

Insulet (PODD) market cap in 2026 was $11.50B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.